In just the first nine months of 2025, the pharmaceutical companies Novo Nordisk and Eli Lilly spent $700 million marketing their GLP-1 medications, Wegovy and Ozempic, and Zepbound and Mounjaro, respectively, according to Reuters
Badretdinov, D., Kalimullina, L., & Zefirov, A
Concomitantly, mean systolic blood pressure declines by 35 mmHg, with modest LDL improvements, providing biologically plausible support for downstream cardiovascular risk reduction
If prescribed, medications can be shipped directly to your home with clear self-administration instructions or sent to your local pharmacy for pickup, based on your preference
Last Updated: December 2025